These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11827799)

  • 1. Quickening the pace of anthrax research: three advances point towards possible therapies.
    Chaudry GJ; Moayeri M; Liu S; Leppla SH
    Trends Microbiol; 2002 Feb; 10(2):58-62. PubMed ID: 11827799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax X-rayed: new opportunities for biodefence.
    Stubbs MT
    Trends Pharmacol Sci; 2002 Dec; 23(12):539-41. PubMed ID: 12457764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax: a motor protein determines anthrax susceptibility.
    Hanna PC
    Curr Biol; 2001 Nov; 11(22):R905-6. PubMed ID: 11719234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the pathogenesis and treatment of anthrax toxin-induced shock.
    Li Y; Sherer K; Cui X; Eichacker PQ
    Expert Opin Biol Ther; 2007 Jun; 7(6):843-54. PubMed ID: 17555370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
    Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
    PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
    Lee SC; Yoon MY
    Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenylyl cyclase activity of anthrax edema factor.
    Tang WJ; Guo Q
    Mol Aspects Med; 2009 Dec; 30(6):423-30. PubMed ID: 19560485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
    Xu Q; Hesek ED; Zeng M
    Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
    Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
    Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax toxin: the long and winding road that leads to the kill.
    Abrami L; Reig N; van der Goot FG
    Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling anthrax.
    Friedlander AM
    Nature; 2001 Nov; 414(6860):160-1. PubMed ID: 11700539
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protease cleavage of Bacillus anthracis protective antigen.
    Ezzell JW; Abshire TG
    J Gen Microbiol; 1992 Mar; 138(3):543-9. PubMed ID: 1593265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A receptor-based switch that regulates anthrax toxin pore formation.
    Pilpa RM; Bayrhuber M; Marlett JM; Riek R; Young JA
    PLoS Pathog; 2011 Dec; 7(12):e1002354. PubMed ID: 22174672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.
    Schein CH; Chen D; Ma L; Kanalas JJ; Gao J; Jimenez ME; Sower LE; Walter MA; Gilbertson SR; Peterson JW
    Toxins (Basel); 2012 Nov; 4(11):1288-300. PubMed ID: 23202316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.